Eli Lilly & Co. CEO David Ricks voiced strong support for policy changes that would pass pharmaceutical rebates onto patients at the point of sale, during the company's fourth quarter earnings call Jan. 31.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?